Track the 인바이오 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Chemicals sector, 인바이오 has recorded 56 reports. Market capitalisation: €21.9bn. The latest transaction was disclosed on 21 July 2026 (Purchase). Among the most active insiders: 이혁재. Every trade is free.
52
Insider Decl.
n/a
Thresholds
€14,430
51 ops.
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
Buys €14,430n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,821 of 28,753 companies
51.2
score / 100
Value
65
Quality
37
FCF yld8.9%
Earn yld4.4%
EV/EBITDA10.6x
ROE1.8%
Gross mgn35%
Net mgn3.0%
Debt/EBITDA4.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.